Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Lozano

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Frontiers in Immunology|May 8, 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsRoberto Lozano-Rodríguez, José Avendaño-Ortíz, Verónica Terrón, et al.
Critical Care (London, England)|May 30, 2026
Elevated sCD25 predicts early infection in patients with major burnsLaura Hurtado-Navarro, Eva Flores-Cabeza, Pablo Mata-Martínez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2021
SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, et al.
Clinical and Translational Medicine|October 28, 2021
The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admissionJosé Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, et al.
Ebiomedicine|October 27, 2023
The prognostic impact of SIGLEC5-induced impairment of CD8<sup>+</sup> T cell activation in sepsisRoberto Lozano-Rodríguez, José Avendaño-Ortíz, Karla Montalbán-Hernández, et al.
Signal Transduction and Targeted Therapy|April 2, 2026
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigationFlavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde, et al.
Journal of Clinical Medicine|June 24, 2022
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and TreatmentRoberto Lozano-Rodríguez, Verónica Terrón-Arcos, Raúl López, et al.
Cancers|January 21, 2022
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder CancerCarolina Rubio, José Avendaño-Ortiz, Raquel Ruiz-Palomares, et al.
Cell Reports|January 5, 2022
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19Roberto Lozano-Rodríguez, Jaime Valentín-Quiroga, José Avendaño-Ortiz, et al.
Clinical and Translational Medicine|May 11, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studyRoberto Lozano-Rodríguez, Verónica Terrón-Arcos, Karla Montalbán-Hernández, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Frontiers in Immunology|May 8, 2023
mRNA-1273 boost after BNT162b2 vaccination generates comparable SARS-CoV-2-specific functional responses in naïve and COVID-19-recovered individualsRoberto Lozano-Rodríguez, José Avendaño-Ortíz, Verónica Terrón, et al.
Critical Care (London, England)|May 30, 2026
Elevated sCD25 predicts early infection in patients with major burnsLaura Hurtado-Navarro, Eva Flores-Cabeza, Pablo Mata-Martínez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2021
SARS-CoV-2 Proteins Induce Endotoxin Tolerance Hallmarks: A Demonstration in Patients with COVID-19José Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, et al.
Clinical and Translational Medicine|October 28, 2021
The immune checkpoints storm in COVID-19: Role as severity markers at emergency department admissionJosé Avendaño-Ortiz, Roberto Lozano-Rodríguez, Alejandro Martín-Quirós, et al.
Ebiomedicine|October 27, 2023
The prognostic impact of SIGLEC5-induced impairment of CD8<sup>+</sup> T cell activation in sepsisRoberto Lozano-Rodríguez, José Avendaño-Ortíz, Karla Montalbán-Hernández, et al.
Signal Transduction and Targeted Therapy|April 2, 2026
Acyl-CoA-binding protein (ACBP): a poor-prognosis biomarker in sepsis and a target for disease mitigationFlavia Lambertucci, Omar Motiño, Uxía Nogueira-Recalde, et al.
Journal of Clinical Medicine|June 24, 2022
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and TreatmentRoberto Lozano-Rodríguez, Verónica Terrón-Arcos, Raúl López, et al.
Cancers|January 21, 2022
Toward Tumor Fight and Tumor Microenvironment Remodeling: PBA Induces Cell Cycle Arrest and Reduces Tumor Hybrid Cells' Pluripotency in Bladder CancerCarolina Rubio, José Avendaño-Ortiz, Raquel Ruiz-Palomares, et al.
Cell Reports|January 5, 2022
Cellular and humoral functional responses after BNT162b2 mRNA vaccination differ longitudinally between naive and subjects recovered from COVID-19Roberto Lozano-Rodríguez, Jaime Valentín-Quiroga, José Avendaño-Ortiz, et al.
Clinical and Translational Medicine|May 11, 2022
Prior SARS-CoV-2 infection balances immune responses triggered by four EMA-approved COVID-19 vaccines: An observational studyRoberto Lozano-Rodríguez, Verónica Terrón-Arcos, Karla Montalbán-Hernández, et al.
Pageof 11